NEW YORK, Dec. 03, 2015 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of ERBA Diagnostics, Inc. (“ERBA”) (NYSEMKT:ERB) between April 14, 2014 and November 20, 2015.
You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Southern District of Florida. If you purchased or otherwise acquired ERBA securities between April 14, 2014 and November 20, 2015, your rights may be affected by this action.To get more information go to:
http://zlk.9nl.com/erba-diagnostics
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that, throughout the Class Period, Defendants issued materially false and misleading statements and/or failed to disclose that: (1) ERBA’s accounting of intercompany transactions among its subsidiaries, including its consolidated financial statements, were improper and had an impact on reported assets and liabilities; (2) ERBA lacked adequate controls over financial reporting; (3) ERBA’s financial statements during the Class Period were materially false and misleading; and (4) as a result, Defendants’ statements about ERBA’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
If you suffered a loss in ERBA you have until February 1, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Brown-Forman and Pernod Ricard in Merger Talks to Create World's Largest Spirits Giant
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 



